sotorasib
amgen
['nsclc', 'lung', 'codebreak 200', 'sclc', 'amgen', '$amgn']
amgen announces detailed data from the phase 3 codebreak 200 study for its #krasg12c inhibitor in advanced non-small cell lung cancer #nsclc at #esmo22. press release: $amgn 
Patients. They're why we develop and manufacture innovative human therapeutics to treat serious diseases. Community Guidelines: https://t.co/YlIOJSpwBy